Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.56% is 146% above its 5-year average of -3.43%, around the middle of its 5-year range (-7.94%–8.16%).
134.32% above its 12-month average of -4.54%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.32%.
RETURN ON ASSETS (ROA)
1.56%
RETURN ON ASSETS (ROA) AVG TTM
-4.54%
RETURN ON ASSETS (ROA) AVG 3Y
-5.50%
RETURN ON ASSETS (ROA) AVG 5Y
-3.43%
RETURN ON ASSETS (ROA) AVG 10Y
-5.90%
RETURN ON ASSETS (ROA) AVG 15Y
-8.63%
RETURN ON ASSETS (ROA) AVG 20Y
-13.87%
CURRENT VS TTM AVG
+134.32%
CURRENT VS 3Y AVG
+128.38%
CURRENT VS 5Y AVG
+145.50%
CURRENT VS 10Y AVG
+126.45%
CURRENT VS 15Y AVG
+118.07%
CURRENT VS 20Y AVG
+111.24%
SECTOR MEDIAN · HEALTHCARE
-26.34%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
+105.92%
vs the sector median at left
AtriCure, Inc.
Market Cap
$2.87B
Return on Assets (ROA)
1.56%
TTM Avg
-4.54%
3Y Avg
-5.50%
5Y Avg
-3.43%
Market Cap
$2.87B
Return on Assets (ROA)
10.36%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$2.88B
Return on Assets (ROA)
-52.25%
TTM Avg
-41.76%
3Y Avg
-70.33%
5Y Avg
-55.50%
Market Cap
$2.69B
Return on Assets (ROA)
13.04%
TTM Avg
11.11%
3Y Avg
0.70%
5Y Avg
-8.32%
Market Cap
$2.69B
Return on Assets (ROA)
-20.31%
TTM Avg
-7.83%
3Y Avg
-2.64%
5Y Avg
-2.82%
Market Cap
$3.09B
Return on Assets (ROA)
-57.49%
TTM Avg
-99.67%
3Y Avg
-60.13%
5Y Avg
-103.92%
Market Cap
$2.64B
Return on Assets (ROA)
-21.30%
TTM Avg
-10.65%
3Y Avg
-10.65%
5Y Avg
-10.65%
Market Cap
$2.64B
Return on Assets (ROA)
-6.16%
TTM Avg
-19.77%
3Y Avg
-17.54%
5Y Avg
-23.06%
Market Cap
$3.15B
Return on Assets (ROA)
5.84%
TTM Avg
-21.93%
3Y Avg
-47.49%
5Y Avg
-47.67%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.87B | 1.56% | -4.54% | -5.50% | -3.43% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 10.36% | 11.11% | 1.40% | -7.68% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | -52.25% | -41.76% | -70.33% | -55.50% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 13.04% | 11.11% | 0.70% | -8.32% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | -20.31% | -7.83% | -2.64% | -2.82% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | -57.49% | -99.67% | -60.13% | -103.92% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | -21.30% | -10.65% | -10.65% | -10.65% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -6.16% | -19.77% | -17.54% | -23.06% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 5.84% | -21.93% | -47.49% | -47.67% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | -44.17% | -37.77% | -27.61% | -21.12% |
ROA
1.6%
ROE
2.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -1.75% |
| 2024-12-31 | -7.34% |
| 2023-12-31 | -4.96% |
| 2022-12-31 | -7.94% |
| 2021-12-31 | 8.16% |
| 2020-12-31 | -6.74% |
| 2019-12-31 | -6.31% |
| 2018-12-31 | -5.92% |
| 2017-12-31 | -10.05% |
| 2016-12-31 | -12.06% |
| 2015-12-31 | -9.96% |
| 2014-12-31 | -10.23% |
| 2013-12-31 | -10.24% |
| 2012-12-31 | -23.23% |
| 2011-12-31 | -16.11% |
| 2010-12-31 | -11.25% |
| 2009-12-31 | -47.15% |
| 2008-12-31 | -23.44% |
| 2007-12-31 | -24.43% |
| 2006-12-31 | -35.06% |
| 2005-12-31 | -25.35% |
| 2004-12-31 | -74.25% |
| 2003-12-31 | -48.16% |
| 2002-12-31 | -51.35% |
| 2001-12-31 | -175.33% |
